Details for New Drug Application (NDA): 203132
✉ Email this page to a colleague
The generic ingredient in CEFOTAXIME SODIUM is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.
Summary for 203132
Tradename: | CEFOTAXIME SODIUM |
Applicant: | Hospira |
Ingredient: | cefotaxime sodium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 203132
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Feb 19, 2016 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
Approval Date: | Feb 19, 2016 | TE: | RLD: | No |
Complete Access Available with Subscription